You are here

Brincidofovir

Once the center of a public storm of anger over denied drug, Chimerix now can’t even recruit patients for their trials

Endpoints

Thu, 05/9/19 - 10:48 am

clinical trials

Chimerix cuts workforce by 20 percent after 'unexpected' trial results

Bizjournals.com

Tue, 03/1/16 - 08:58 am

Chimerix scraps two PhIII trials as it regroups in wake of a setback

Fierce Biotech

Mon, 02/22/16 - 10:09 am

clinical trials

Chimerix shares crater after late-stage trial fails

Marketwatch

Mon, 12/28/15 - 09:52 am

clinical trials

Trial enrollment drives Durham-based Chimerix stock to all-time high

Bizjournals.com

Mon, 08/3/15 - 04:57 pm

clinical trials

Durham's Chimerix hits 'major milestone' in drug trial enrollment

Bizjournals.com

Tue, 06/9/15 - 10:10 am

cytomegalovirus

Chimerix to stop participation in clinical studies of Ebola drug

Yahoo/Reuters

Sat, 01/31/15 - 10:05 am

The Rationale For Using Brincidofovir (BCV) In Ebola Patients

Forbes

Thu, 11/13/14 - 08:22 am

Chimerix drug used for Ebola shows promise in respiratory cases

Reuters

Wed, 10/8/14 - 10:04 am

FDA approves emergency use of Chimerix's Brincidofovir

Seeking Alpha

Tue, 10/7/14 - 07:43 am

Chimerix Wants Its Piece of the Ebola Pie

24/7 Wall St

Mon, 10/6/14 - 10:54 am

Chimerix continues to surge after decision to help ailing 7-year-old boy

Marketwatch

Fri, 03/14/14 - 08:38 am

Company Makes Drug Available To Ailing Boy Following Public Outcry

Forbes

Wed, 03/12/14 - 10:00 am

Chimerix under pressure to help dying boy with experimental drug

Marketwatch

Tue, 03/11/14 - 11:28 am

compassionate use guidelines